EuroIntervention | Your reference journal for coronary, valvular and structural interventions

Your reference journal for coronary, valvular and structural interventions

France LILI: Long-term predictors of TVF post-IVL

Research Correspondence

Aug 7

France LILI: Long-term predictors of TVF post-IVL

Benjamin Honton, Guillaume Cayla, et al.

The France LILI registry provides evidence supporting intravascular lithotripsy (IVL) as an effective and safe adjunct in treating calcified coronary lesions, with the number of pulses administered identified as a new independent predictor of 12-month target vessel failure.

Editorial

Aug 7

M-TEER in moderate SMR

Marianna Adamo, Mauro Riccardi

This study evaluates the use of mitral transcatheter edge-to-edge repair (M-TEER) in patients with moderate secondary mitral regurgitation, suggesting it may have a role in this population.

free

Original Research

Aug 6

Outcomes in MiCLASP patients with moderate FMR

Philipp Lurz, Jörg Hausleiter, et al.

Patients with symptomatic moderate functional mitral regurgitation (FMR) experienced significant mitral regurgitation reduction, functional capacity improvements, and low adverse event rates after mitral transcatheter edge-to-edge repair (M-TEER) with the PASCAL system, comparable to those with ≥moderate-severe FMR.

Outcomes in MiCLASP patients with moderate FMR

Expert Review

Aug 5

LAA closure device embolisation

Joelle Kefer, Jens Erik Nielsen-Kudsk, et al.

This study discusses the management of left atrial appendage closure (LAAC) device embolisation, a rare but potentially fatal complication of this procedure, with recommendations for percutaneous or surgical retrieval approaches based on the device's anatomical location.

free

NEW ISSUE

Aug 4

A new issue of EuroIntervention

Device embolisation during LAAC; prognostic value of MAC using CT scans for TEER; the PASCAL transcatheter valve repair system: 1-year outcomes of the MiCLASP and TriCLASP studies; 1-year results of the REDUCER-I study; 12-month results from the France LILI registry on TVF post-IVL; and more

Research Correspondence

Aug 1

Nicardipine and coronary hyperaemia

Michele Mattia Viscusi, Bernard De Bruyne, et al.

This study found that nicardipine, a calcium channel blocker, can induce transient maximal hyperaemia and produces FFR and PPG values that agree well with those obtained using papaverine, the standard agent.

Original Research

Jul 30

SSO2 therapy in routine STEMI care

Tobias König, Andreas Schäfer, et al.

This study found that the use of supersaturated oxygen (SSO2) therapy after successful primary percutaneous coronary intervention (PCI) in patients with acute anterior myocardial infarction was associated with significantly reduced final infarct size and microvascular obstruction compared to standard PCI alone.

Meet Cory, your AI Assistant!

Enhance your reading experience and get deeper insights on complex topics.

Learn more

Balloon-assisted mitral leaflet translocation for TMVR

Flashlight

Aug 4

Balloon-assisted mitral leaflet translocation for TMVR

Vlasis Ninios, Ilias Ninios, et al.

A 77-year-old female with severe mitral annular calcification and heart failure underwent successful transfemoral transcatheter mitral valve replacement using the balloon-assisted translocation of the anterior mitral leaflet (BATMAN) technique to mitigate the risk of left ventricular outflow tract obstruction.

Editorial

Jul 31

Supersaturated oxygen to reduce infarct size

Gregg W. Stone, Oludamilola Akinmolayemi

The study discusses the use of optimized supersaturated oxygen (SSO2) therapy in addition to percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) patients, suggesting it may reduce infarct size.

free

Viewpoint

Jul 29

Factor XI inhibition in ACS

Renato D. Lopes, Alexander C. Fanaroff

The study evaluates the use of dual pathway inhibition, combining dual antiplatelet therapy with a factor XIa inhibitor, as a potential strategy to reduce residual thrombotic risk in patients with acute coronary syndrome.

free

Research Correspondence

Jul 28

Resting pullback pressure gradient

Koshiro Sakai, Allen Jeremias, et al.

This study demonstrated a strong correlation and substantial agreement between resting and hyperaemic pullback pressure gradient (PPG) in assessing coronary artery disease patterns, with resting PPG showing comparable diagnostic performance and predictive capacity for optimal PCI outcomes.

new EIJ podcast

Jul 23

Turning Point: a new podcast by EuroIntervention

Turning Point is a new podcast series brought to you by EuroIntervention. Listen as clinicians, researchers, mentors, and innovators explore the pivotal moments that defined their journeys and shaped the evolution of interventional cardiology. Episode 1 with Patrick W. Serruys is out now!

Editorial

Jul 25

DAPT de-escalation post-ACS

Thomas Cuisset, Guillaume Cayla

The 4D-ACS trial suggests that a shorter DAPT course followed by low-dose prasugrel monotherapy can reduce bleeding risk without compromising ischemic outcomes in ACS patients undergoing PCI.

free

Original Research

Jul 24

Low-dose prasugrel following one-month DAPT in ACS

Youngwoo Jang, Woong Chol Kang, et al.

In ACS patients treated with drug-coated stents, a 1-month prasugrel-based DAPT strategy followed by prasugrel 5 mg monotherapy reduced net adverse clinical events by 49% compared to 12-month DAPT, primarily by lowering bleeding events without increasing ischaemic risk.